Skip to main content

MR and CT Imaging of Thyroid Cancer

  • Chapter
  • First Online:
Thyroid Cancer

Abstract

Radiologic imaging is often not necessary for the preoperative staging of early thyroid carcinoma. However, with locally advanced disease, MRI and CT may be necessary to assess invasion of adjacent structures such as the esophagus, trachea, and neurovascular structures. Postoperative imaging of thyroid carcinoma is guided by the results of radioactive iodine metastatic disease for those patients with papillary and follicular carcinoma. With complete thyroidectomy and negative metastatic thyroid survey, imaging may not be necessary. For those patients with tumors that have non-avid iodine uptake and for those patients with medullary and anaplastic thyroid cancer, PET/CT is the modality of choice. For patients with metastatic disease, advanced imaging is required. Non-contrast CT is best for evaluating pulmonary nodules.

MRI is often best for identifying metastatic disease to the brain, upper neck, spine, liver, and skeletal structures.

New ablative technologies of cryoablation and RF ablation are available to treat metastatic thyroid carcinoma.

Interdisciplinary approach between endocrinologists, nuclear medicine physicians, and radiologists is essential to the diagnosis, staging, and treatment of advanced thyroid carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Weiss RE, Lado-Abeal J. Thyroid nodules: diagnosis and therapy. Curr Opin Oncol. 2002;14:46–52.

    Article  PubMed  Google Scholar 

  2. Blum M. Nonisotopic imaging of the neck in patients with thyroid nodules or cancer. In: Wartofsky L, editor. Thyroid cancer; a comprehensive guide to clinical management. Totowa, NJ: Springer Science+Business Media New York; 2000. p. 9–34.

    Google Scholar 

  3. Smoker WRK, Harnsberger HR, Reede DL, Holliday RA, Som PM, Bergeron RT. The neck. In: Som PM, Bergeron RT, editors. Head and neck imaging. 2nd ed. St. Louis: Mosby Yearbook; 1991. p. 497–592.

    Google Scholar 

  4. Becker M. Other infrahyoid neck lesions. In: Mafer MF, Valvassori GE, Becker M, editors. Imaging of the head and neck. 2nd ed. Stuttgart: Thieme; 2005. p. 780–845.

    Google Scholar 

  5. Som PM, Brandwein M, Lidov M, et al. The varied presentations of papillary thyroid cervical nodal disease: CT and MR findings. AJNR. 1994;15:1123–8.

    CAS  PubMed  Google Scholar 

  6. Som PM, Curtin HD, Mancuso AA. Imaging-based nodal classification for evaluation of neck metastatic adenopathy. AJR. 2000;174:837–44.

    Article  CAS  PubMed  Google Scholar 

  7. Seo YL, Yoon DY, Lim KJ, et al. Locally advanced thyroid cancer: can CT help in prediction of extrathyroidal invasion to adjacent structures? AJR. 2010;195:240–4.

    Article  Google Scholar 

  8. Gross ND, Weissman JL, Talbot JM, Anderson PE, Wax NK, Johen JI. MRI detection of cervical metastases from differentiated thyroid carcinoma. Laryngoscope. 2001;111:1905–9.

    Article  CAS  PubMed  Google Scholar 

  9. Ohno Y, Koyama H, Yoshikawa T, et al. N stage disease in patients with non-small cell lung cancer: efficacy of quantitative and qualitative assessment with STIR turbo spin echo imaging, diffusion-weighted MR imaging and fluorodeoxyglucose PET/CT. Radiology. 2011;26:605–15.

    Article  Google Scholar 

  10. Kim S, Loevner L, Quon H, et al. Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res. 2009;15:986–94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Schroder RJ, Rost B, Hidajat N, Rademaker J, Felix R, Maurer J. Value of contrast-enhanced ultrasound vs. CT and MR in palpable enlarged lymph node of the head and neck. Rofo. 2002;174:1099–106.

    Article  PubMed  Google Scholar 

  12. Curtin HD, Ishwaran H, Mancuso AA, et al. Comparison of CT and MR imaging in staging of neck metastases. Radiology. 1998;207:123–30.

    Article  CAS  PubMed  Google Scholar 

  13. Yousem DM, Som PM, Hackney DB, et al. Central necrosis and extracapsular neoplastic spread in cervical lymph nodes: MR imaging versus CT. Radiology. 1992;182:753–9.

    Article  CAS  PubMed  Google Scholar 

  14. Von den Brekel MWM. Lymph node metastasis: CT and MRI. Eur J Radiol. 2000;22:230–8.

    Article  Google Scholar 

  15. King AD, Tse GM, Yuen EH, et al. Comparison of CT and MR imaging for the detection of extranodal neoplastic spread in metastatic neck nodes. Eur J Radiol. 2004;52:264–70.

    Article  PubMed  Google Scholar 

  16. James C, Starks M, MacGilloroy DC, White J. The use of imaging studies in the diagnosis and management of thyroid cancer and hyperparathyroidism. Surg Oncol Clin N Am. 1999;8:145–69.

    CAS  PubMed  Google Scholar 

  17. Johnson NA, Tublin ME. Postoperative surveillance of differentiated thyroid carcinoma: rationale, techniques, and controversies. Radiology. 2008;249:429–44.

    Article  PubMed  Google Scholar 

  18. Benchaou M, Lehmann W, Slosmann DO, et al. The role of FDG-PET in the preoperative assessment of N-staging in head and neck cancer. Acta Otolaryngol. 1996;116:332–5.

    Article  CAS  PubMed  Google Scholar 

  19. Popperl G, Lang S, Dogdelen O. Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer. Rofo Fortschr. 2002;174:714–20.

    Article  CAS  Google Scholar 

  20. Takashima S, Matsushita T, Takayama F, Kadoya M, Fujimori M, Kobayashi S. Prognostic significance of magnetic resonance findings in advanced papillary thyroid cancer. Thyroid. 2001;11:1153–9.

    Article  CAS  PubMed  Google Scholar 

  21. Takashima S, Takayama F, Wang JC, Kobayashi S, Kodoya M. Using MR imaging to predict invasion of the recurrent laryngeal nerve by thyroid cancer. AJR Am J Roentgenol. 2003;180:837–42.

    Article  PubMed  Google Scholar 

  22. Wang JC, Takashima S, Takayama F, Kawakami S, Saito A, Matsushita T, Matsuba H, Kobayashi S. Tracheal invasion by thyroid carcinoma: prediction using MR imaging. Am J Roentgenol. 2001;177:926–36.

    Article  Google Scholar 

  23. Saab G, Driedger AA, Pavlosky W, et al. Thyroid-stimulating hormone simulated fused positron emission tomography/computed tomography in the evaluation of recurrence in I131-negative papillary thyroid carcinoma. Thyroid. 2006;16:267–72.

    Article  CAS  PubMed  Google Scholar 

  24. Becker M, Schroth G, Zbaren P, et al. Long-term changes induced by high-dose irradiation of the head and neck region: image findings. Radiographics. 1997;17:5–26.

    Article  CAS  PubMed  Google Scholar 

  25. Song HJ, Xue YL, Xu YH, Qiu ZL, Luo QY. Rare metastases of differentiated thyroid carcinoma. Endocr Relat Cancer. 2011;18:R165–74.

    Article  CAS  PubMed  Google Scholar 

  26. Haq M, Harmer C. Differentiated thyroid carcinoma with distant metastases at presentation: prognostic factors and outcome. Clin Endocrinol. 2005;63:87–93.

    Article  CAS  Google Scholar 

  27. Shammas A, Degirmenci B, Mountz JM, et al. 18F-FDG PET/CT in patients with suspected or metastatic well-differentiated thyroid cancer. J Nucl Med. 2007;48:221–6.

    CAS  PubMed  Google Scholar 

  28. Chiu AC, Delpassand ES, Sherman SI. Prognosis and treatment of brain metastasis in thyroid carcinoma. J Clin Endocrinol Metab. 1997;82:3637–42.

    Article  CAS  PubMed  Google Scholar 

  29. Xu YH, Song HJ, Qiu ZL, Luo QY. Brain metastases with exceptional features from papillary thyroid carcinoma; report of three cases. Hell J Nucl Med. 2011;14:56–9; nucmed.web.auth.gr/magazine/eng/jan11/10.pdf.

    PubMed  Google Scholar 

  30. Dupuy DE, Monchick JM, Decrea C, Pisharodi L. Radio-frequency ablation of regional recurrence from well-differentiated thyroid malignancy. Surgery. 2001;130:971–7.

    Article  CAS  PubMed  Google Scholar 

  31. Lee JM, Jin GY, Goldberg SN, Lee YC, Chung GH, Han YM, Lee SY, Kim CS. Percutaneous radio-frequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology. 2004;230:125–34.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kenneth D. Burman MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this chapter

Cite this chapter

Jelinek, J., Young, R., Smith, L.O., Burman, K.D. (2016). MR and CT Imaging of Thyroid Cancer. In: Wartofsky, L., Van Nostrand, D. (eds) Thyroid Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3314-3_45

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3314-3_45

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-3312-9

  • Online ISBN: 978-1-4939-3314-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics